Home

hektár Laza bumm z fever kawasaki Ütközés tanfolyam Hajnal átutalás

Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during  COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in  Children
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children

Understanding Kawasaki Disease
Understanding Kawasaki Disease

Diagnosis and Management of Kawasaki Disease | AAFP
Diagnosis and Management of Kawasaki Disease | AAFP

Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's  Disease | NEJM
Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki's Disease | NEJM

Revised recommendations of the Italian Society of Pediatrics about the  general management of Kawasaki disease | Italian Journal of Pediatrics |  Full Text
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease |  Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease | Circulation

Kawasaki disease: AHA statement and recommendations
Kawasaki disease: AHA statement and recommendations

The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical  & Translational Immunology - Wiley Online Library
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library

Kawasaki Disease | Pediatrics Clerkship | The University of Chicago
Kawasaki Disease | Pediatrics Clerkship | The University of Chicago

Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A  Scientific Statement for Health Professionals From the American Heart  Association | Circulation
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation

2021 American College of Rheumatology/Vasculitis Foundation Guideline for  the Management of Kawasaki Disease
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease

Efficacy of primary treatment with immunoglobulin plus ciclosporin for  prevention of coronary artery abnormalities in patients with Kawasaki  disease predicted to be at increased risk of non-response to intravenous  immunoglobulin (KAICA): a
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a

Frontiers | Risk Factors of Coronary Artery Abnormality in Children With  Kawasaki Disease: A Systematic Review and Meta-Analysis
Frontiers | Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis

Evaluation of suspected Kawasaki disease - UpToDate
Evaluation of suspected Kawasaki disease - UpToDate

Frontiers | Overlapping Features in Kawasaki Disease-Related Arthritis and  Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan
Frontiers | Overlapping Features in Kawasaki Disease-Related Arthritis and Systemic-Onset Juvenile Idiopathic Arthritis: A Nationwide Study in Japan

Diagnosis and Management of Kawasaki Disease | AAFP
Diagnosis and Management of Kawasaki Disease | AAFP

Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A  description of the phenotypes and comparison with historical cohorts of  children with Kawasaki disease and myocarditis | PLOS ONE
Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis | PLOS ONE

Infliximab versus second intravenous immunoglobulin for treatment of  resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre  comparative effectiveness trial - The Lancet Child & Adolescent Health
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health

Kawasaki Disease Project
Kawasaki Disease Project

An Overview of Kawasaki Disease
An Overview of Kawasaki Disease

An Overview of Kawasaki Disease
An Overview of Kawasaki Disease

Refractory Kawasaki disease: diagnostic and management challenges | PHMT
Refractory Kawasaki disease: diagnostic and management challenges | PHMT

Initial treatment for Kawasaki disease - UpToDate
Initial treatment for Kawasaki disease - UpToDate

Revised recommendations of the Italian Society of Pediatrics about the  general management of Kawasaki disease | Italian Journal of Pediatrics |  Full Text
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text

16: Kawasaki Disease with Recrudescent Guest Dr. Tremoulet - The Curbsiders
16: Kawasaki Disease with Recrudescent Guest Dr. Tremoulet - The Curbsiders

2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease |  SpringerLink
2021 Update on the Clinical Management and Diagnosis of Kawasaki Disease | SpringerLink

Kawasaki Disease - ScienceDirect
Kawasaki Disease - ScienceDirect